[1] |
XIAO Xiumei, LIANG Chao, LIU Caihong, LI Xiaoguang.
Comparison of SARS-CoV-2 neutralizing antibody and specific antibody determination results
[J]. Laboratory Medicine, 2023, 38(4): 352-356.
|
[2] |
HU Yan, SHEN Ge, LI Qiong, ZENG Ziyan, , YANG Gang, LI Ping, CHEN Yufeng, ZHANG Zhen, XIE Xiaobing.
Roles of 2 SARS-CoV-2 antibody assays in the diagnosis of corona virus disease 2019
[J]. Laboratory Medicine, 2020, 35(12): 1294-1297.
|
[3] |
WU Jun, LU Renquan, GUO Lin.
Role of serum CgA determination for neuroendocrine neoplasma
[J]. Laboratory Medicine, 2019, 34(2): 122-125.
|
[4] |
YE Zhenxuan, YANG Biwei, ZHOU Wenjing, LIU Qiang, LI Hongmei, ZHANG Haiyan, REN Zhijing, ZHANG Hua.
Screening of specific anti-mitochondrial antibody-M2 in 36 459 healthy subjects in Guiyang
[J]. Laboratory Medicine, 2018, 33(3): 205-208.
|
[5] |
ZHAO Yinxia, OU Meixian, QU Yi, LU Youli, ZHANG Meiwei, LI Shuijun.
Determination of human serum ouabain by UPLC-MS/MS and methodology comparison
[J]. Laboratory Medicine, 2018, 33(11): 1013-1016.
|
[6] |
QI Yingjie, SHI Yuru, LIU Ting, YUE Li, ZHAO Changcheng, WANG Yun, MA Xiaoling.
Establishment and preliminary application of optimal cut-off value of anti-multi-epitope fusion antigen IgG antibody of Mycobacterium tuberculosis
[J]. Laboratory Medicine, 2018, 33(10): 899-902.
|
[7] |
XIE Liangcai, FAN Wen, XU Lei, XU Rong, LIU Tianchun.
False negative interference of RF on serum HBeAg by ELISA
[J]. Laboratory Medicine, 2017, 32(9): 765-768.
|
[8] |
LING Yingchun, ZHOU Yueqin, DUAN Di, HU Lingmin.
Determination of central nervous system specific protein for senile dementia
[J]. Laboratory Medicine, 2017, 32(11): 1021-1023.
|
[9] |
YAN Jun, YANG Wei, ZHAI Shuanzhu, XUE Zhixin, YU Peng, ZHOU Zeqi.
Preparation of polyclonal antibody and development of a competitive ELISA for fungal (1,3)-beta-D-glucan
[J]. Laboratory Medicine, 2015, 30(9): 931-933.
|
[10] |
SUN Lishan, WANG Mingdong, LU Liu, LIU Yingbing, LU Lin, GUO Jinhu, FAN Lieying.
Establishment of an ELISA for the quantitative measuring of glucagon-like peptide 1 and the primary clinical application
[J]. Laboratory Medicine, 2015, 30(8): 835-840.
|
[11] |
ZHU Qinghui..
Pay close attention to false positivity in the determinations of anti-HCV and anti-TP antibodies
[J]. Laboratory Medicine, 2015, 30(12): 1163-1166.
|
[12] |
CHEN Cuncun, FAN Lieying..
The study progress of false positivity in screening assay for detecting anti-HCV antibody and anti-TP antibody and its strategy
[J]. Laboratory Medicine, 2015, 30(12): 1167-1174.
|
[13] |
MENG Cunren, TANG Jing, ZHANG Zhaoxia..
Analysis on repeatability and diagnostic threshold value of 2 ELISA systems for anti-HCV antibody determination
[J]. Laboratory Medicine, 2015, 30(12): 1175-1180.
|
[14] |
XU Xiaofeng, JIANG Minglei, LU Renquan, ZOU Chunyuan, GONG Zhiyun, SHEN Li, GUO Lin.
Study on the correlation between anti-TP antibody S/CO ratio by chemiluminescence immunoassay and positive results by confirmation assay
[J]. Laboratory Medicine, 2015, 30(12): 1185-1189.
|
[15] |
CAI Xushan, QI Jiehua, CHEN Yu, WANG Dongjiang, WU Shoule..
Investigation on the positive cut off value of anti-TP antibody in pregnant women by chemiluminescence immunoassay
[J]. Laboratory Medicine, 2015, 30(12): 1190-1192.
|